Pilot dose‐finding and safety study of bivalirudin in infants <6 months of age with thrombosis

Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention

A. Michael Lincoff, John A. Bittl, Robert A. Harrington et al. · JAMA · 2003 · 1.2K citations

Medicine, Cardiology, Pharmacotherapy +17

Heparin: Mechanism of Action, Pharmacokinetics, Dosing Considerations, Monitoring, Efficacy, and Safety

Jack Hirsh, Theodore E. Warkentin, James E. Dalen et al. · CHEST Journal · 1995 · 390 citations

Pharmacy, Pharmacokinetics, Pharmacology +7

Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study

John A. Bittl, Bernard Chaitman, Frederick Feit et al. · American Heart Journal · 2001 · 315 citations

Medicine, Cardiology, Pharmacotherapy +16

Developmental Hemostasis: Relevance to Thromboembolic Complications in Pediatric Patients

Maureen Andrew · Thrombosis and Haemostasis · 1995 · 218 citations

Medicine, Hematology, Pediatrics +16

Anticoagulant Activity of Hirulog™, a Direct Thrombin Inhibitor, in Humans

Irving H. Fox, Adrian Dawson, Peter Loynds et al. · Thrombosis and Haemostasis · 1993 · 181 citations

Medicine, Pharmacokinetics, Pharmacology +17